A Few Steps Ahead the State of Kazakhstan’s Pharmaceutical Industry

Abstract

The openness of the economy to the world market has many advantages but the lack of the protection of the domestic industry also imposes problems on the development of the domestic economy. In this sense, Kazakhstan, as part of the global market, is seeking its way in case of pharmaceutical industry. Currently the pharmaceutical sector is still in infancy stage of development to attempt the formation of an own independent pharmaceutical industry, the government has utilized several state programs and certain measures to stimulate the development of the pharmaceutical industry. The pharmaceutical market in Kazakhstan depends on foreign import drugs. In this article, we are considering the problems of Research and Development of original drugs in Kazakhstan. This paper explains the present barriers of the locally produced original drugs. The paper elaborates to eliminate public mismanagement, ineffective allocation of finance, to avoid loopholes in legislation (patent, fiscal, tax and preferences), to improve a cluster collaboration platform and economic barriers, commercialization technologies and not sufficient qualification of personnel and marketing and others. The theoretical and practical methods as well as administrative instruments of public services show the necessity of the adaptation of new approaches. This measure should be based on well-known overseas practices and legislative features that need to be applied accurately taking into account the specifications of Kazakhstan (legislation system, automation and digitalization process, big data, market circumstances and globalization impact and others). The paper is based on quantitative and qualitative data from scientific sources and legislation, official statistics, documents.